Get to know biosimilars
Developing Biosimilars: from innovator biologics to biosimilar medicine
Learn more
card
Developing the totality of evidence for biosimilars: regulatory considerations for the healthcare community
Learn more
card-img
Health Canada has updated their fact sheet on biosimilars. Read the August 2019 update here
Learn more
substitution and interchangeability
Distinct therapeutic choices
Learn more
Substitution and interchangeability: Defining the terms
Learn more
pr_card3
Current Canadian landscape on biosimilar naming
Learn more
substitution and interchangeability
interchangeability and substitution
worldwide
View map
gd_card2
How Health Canada
defines
interchangeability
Learn more
biologic-biosimilar
Biologic and biosimilar naming in Canada: Health Canada’s notice to stakeholders
Learn more
extensive-review
Health Canada's notice to stakeholders: Summary of the discussion and review with stakeholders
Learn more